In contrast, it slowed tumor growth in immunocompetent C57BL/6 mice (Figure 5E and Supplemental Figure 8F) and increased the number of tumor-infiltrating CD8+ T cells (Figure 5, F–H). The gene discussed is CD8A; the disease is neoplasm.